Health Care Related Organization – Page 57

Healthcare M&A and IRA Price Negotiations: Key Trends to Watch Amidst Political Shifts

1 year ago talkbio0Tagged Acquisitions, Drug Industry, drug price, Healthcare M&A, Inflation, Ira (eukaryote), Mediation, Medicare, mergers, Negotiation Program, Prices, trends qualifier

Healthcare M&A, IRA Price Negotiations, Medicare Drug Price Negotiation Program, Inflation Reduction Act, Pharmaceutical Industry Trends, Mergers and Acquisitions Outlook 2024

Coherus BioSciences Completes Strategic Shift with $483M Sale of Last Biosimilar Asset

1 year ago talkbio0Tagged Biosciences, Biosimilars, Biotechnology, Coherus, Drug Industry, strategic pivot

Coherus BioSciences, biosimilars, strategic pivot, pharmaceutical industry, biotechnology

Roche and COUR Pharmaceuticals Collaborate on Autoimmune Disease Treatment in Deal Worth Over $900 Million

1 year ago talkbio0Tagged antigen-specific immune tolerance platform, Autoimmune Diseases, Collaboration, COUR, genentech, Roche (company)

Roche, COUR Pharmaceuticals, autoimmune disease, Genentech, antigen-specific immune tolerance platform, biotech collaboration

Sanofi Invests €1 Billion in Beijing to Enhance Insulin Production Capacity

1 year ago talkbio0Tagged Beijing, Drug Industry, Insulin, Investments, production, sanofi

Sanofi, insulin production, Beijing, investment, pharmaceutical industry

Novartis Announces 139 Layoffs in New Jersey Amid Ongoing Restructuring Efforts

1 year ago talkbio0Tagged Drug Industry, New Jersey, Novartis, restructuring

Novartis, layoffs, New Jersey, restructuring, pharmaceutical industry

CDC Faces Uncertainty Amid Leadership Change and Funding Threats

1 year ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Dr. Mandy, Funding, health threats, Leadership Change, public health medicine (field), threat

CDC, leadership change, funding threats, public health, emerging health threats, Dave Weldon, Dr. Mandy Cohen

Biopharma Companies Continue Layoffs: Novartis, Recursion, and Kronos Reduce Staff Amid Industry Restructuring

1 year ago talkbio0Tagged Biopharma layoffs, cost-cutting measures, Drug Industry, Novartis, Recursion, restructuring

Biopharma layoffs, Novartis restructuring, Recursion, Kronos, pharmaceutical industry, workforce reduction, cost-cutting measures

AstraZeneca’s Truqap Achieves Phase III Success in Prostate Cancer, Reviving Hopes After Breast Cancer Setback

1 year ago talkbio0Tagged Antiandrogen therapy, AstraZeneca, Malignant neoplasm of prostate, Metastatic to, Phase 3 Clinical Trials, Progression-Free Survival, PTEN-deficient, Radiographic, rPFS, Truqap

AstraZeneca, Truqap, prostate cancer, Phase III trial, PTEN-deficient metastatic hormone-sensitive prostate cancer, radiographic progression-free survival (rPFS), abiraterone, androgen deprivation therapy (ADT).